FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and pharmacy and deals with pharmaceutical device which contains biological materials such as vaccines, which can be stabilised in certain glass-like water-soluble materials. It was suggested to form these glass-like materials in form of powder, suspended on non-water liquid for injection to patient. Glass-like material is placed on porous membrane, separately from eluent. When it is necessary to introduce biological material, eluent can be passed through membrane, solving glass and ensuring transfer of substance together with liquid into patient's body.
EFFECT: elaboration of improved device for introduction and storage of pharmaceutical product.
14 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE SILICONE-BASED COMPOSITIONS FOR DELIVERING THERAPEUTIC AGENTS | 2014 |
|
RU2705986C2 |
| DRUG DELIVERY DEVICE CONTAINING SILICON-BASED CARRIER PARTICLES | 2014 |
|
RU2695536C2 |
| BIODEGRADABLE DEVICES BASED ON SILICON FOR THERAPEUTIC AGENTS DELIVERY | 2011 |
|
RU2640918C2 |
| SET FOR PHARMACEUTICAL COMPOSITION PREPARING | 2002 |
|
RU2279292C2 |
| ELECTRO-SPINNED AMORPHOUS PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2331411C2 |
| BAG FOR STERILE PRODUCT SOLUTION | 2017 |
|
RU2732111C2 |
| SOLID DELIVERY SYSTEMS FOR CONTROLLED RELEASE OF INCLUDED MOLECULES AND METHOD FOR THEIR PREPARATION | 1995 |
|
RU2177785C2 |
| DEVICE USED DURING INJECTION OF LIQUIDS INTO AMBULATORY PATIENT, DEVICE FOR USING IN INJECTION OF CURATIVE AGENT WITH CONTROLLABLE NORM OF CONSUMPTION (VERSIONS) | 1992 |
|
RU2131270C1 |
| TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
| LIQUID DELIVERY DEVICE | 1994 |
|
RU2131273C1 |
